Wir verwenden Cookies und Analyse-Tools, um die Nutzerfreundlichkeit der Internet-Seite zu verbessern und für Marketingzwecke. Wenn Sie fortfahren, diese Seite zu verwenden, nehmen wir an, dass Sie damit einverstanden sind. Zur Datenschutzerklärung.
The Cure Fraction in Cancer Clinical Trials
Details
This market-leading book offers a readable introduction to the statistical inference of cure rate estimation in cancer trials when the bounded cumulative hazard model is employed using right and interval censored data. Its overarching goal is to provide readers with the knowledge necessary to select appropriate techniques for estimating the cure fraction in cancer studies when some cancer patients in a clinical trial are cured. Chapter topics include aspects of cancer clinical trials and cure fraction and types of censoring in survival data, non parametric estimation techniques of the cure fraction for right and interval censoring cases using some common techniques, inferences about cure fraction in the parametric case without covariates, parametric estimation of the cure fraction using the same censoring types when some covariates are employed in the analysis.
Autorentext
Assistant Professor,Survival Data AnalysisDepartment of Mathematics, Hebron University,Hebron, West Bank, Palestinian Territories.
Weitere Informationen
- Allgemeine Informationen
- GTIN 09783659109164
- Sprache Englisch
- Auflage Aufl.
- Größe H220mm x B12mm x T150mm
- Jahr 2012
- EAN 9783659109164
- Format Kartonierter Einband (Kt)
- ISBN 978-3-659-10916-4
- Titel The Cure Fraction in Cancer Clinical Trials
- Autor Bader Aljawadi , Mohd Rizam Aabu Bakar , Noor Ibrahim
- Untertitel Estimation of the Cure Fraction in Cancer Clinical Trials Using BCH Model for Right and Interval Censored Data
- Gewicht 294g
- Herausgeber LAP Lambert Academic Publishing
- Anzahl Seiten 208
- Genre Mathematik